Results 111 to 120 of about 850,964 (168)

Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude. [PDF]

Can J Psychiatry
Chisamore N, Kaczmarek ES, Doyle Z, Johnson DE, Weiglein G, Meshkat S, Brudner RM, Blainey MG, Riva-Cambrin J, McIntyre RS, Rosenblat JD.   +10 more
europepmc   +1 more source

Psilocybin in palliative care: Advancing spiritual well-being, quality of life and cultural recognition

Traditional Indigenous medicine used plants with psychoactive properties in practices for thousands of years. Western medicine has a renewed interest in using psilocybin-assisted-psychotherapy in healthcare, with recent research emerging in palliative ...
Suykens, Ashley, Petrucka, Pammla
core  

AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression. [PDF]

J Manag Care Spec Pharm
Flavin B, Small G, Dragovich C, Dragovich C, Haumschild R, Richardson T, Shannon MH.   +6 more
europepmc   +1 more source

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica. [PDF]

Front Psychiatry
Sams CH, Davis J, Ramdas A, Delgoda R, Vidot D, Reid M, De La Haye W.   +6 more
europepmc   +1 more source

Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review. [PDF]

Life (Basel)
Kéri S.
europepmc   +1 more source

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026). [PDF]

J Clin Med
Anghel T, Cojocaru A, Hogea L, Costea I, Marinca A, Dumache R, Nussbaum L, Trăilă IA.   +7 more
europepmc   +1 more source

Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial. [PDF]

Commun Med (Lond)
Armstrong SB, Levin AW, Sepeda ND, Shaub H, Hunter T, Douglas A, Lancelotta R, Davis AK.   +7 more
europepmc   +1 more source

Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study. [PDF]

BMJ Open
Meyer TD, Vale LN, Ibrahim M, Olmos C, Quevedo J, Soares JC.   +5 more
europepmc   +1 more source

Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence. [PDF]

Ann Med Surg (Lond)
Sabani A, Khatak A.
europepmc   +1 more source

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care. [PDF]

Curr Psychiatry Rep
Geller JA, Pacilio R, Downey AE, Ragnhildstveit A, Raymond-Flesch M, Knatz-Peck S, Gukasyan N.   +6 more
europepmc   +1 more source